Inspiration wins AIM Transaction of the Year Award

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Inspiration Healthcare wins AIM Transaction of the Year Award

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that it has won the AIM Transaction of the Year.

In June 2020, Inspiration Healthcare announced the acquisition of S.L.E. Limited for a consideration of £18.0 million which was raised by way of a Placing and Open Offer to certain institutional and individual investors by Cenkos Securities. S.L.E. is a leader in the design and manufacture of ventilators and capital equipment for neonatal intensive care, treating premature and sick babies. S.L.E.'s products are sold across the world through a distribution network built over many years.

The AIM awards 2020 are sponsored by BDO, in association with the London Stock Exchange Group and have been held each year for the last 25 years to celebrate the outstanding achievements of companies on the world's most successful growth market. The Awards identify the quoted companies and entrepreneurs who have harnessed AIM to help them fulfil their ambition and growth potential in the last twelve months.

Neil Campbell, Chief Executive Officer, commented: "We are delighted to have won AIM Transaction of the Year 2020.  We knew that there was a strong commercial and strategic fit with the acquisition of SLE, bringing two British leaders together to improve the outcomes of premature and sick babies around the world and this award recognises those thoughts.  Doing such a transformational transaction, effectively doubling the size of the company, during lockdown whilst maintaining supply of critical care medical products around the world shows what can be done.  We look forward to making the enlarged Group an even greater success story."

Enquiries:

About Inspiration Healthcare http://www.inspiration-healthcare.com

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

Through investment in research and development the Company has six key own-brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has a range of products for maintaining normothermia pre- during and post-surgery.

In September 2019, the Company acquired Vio Holdings a designer, manufacturer and supplier of single-use respiratory products and sterile medical consumables for £4 million and in June 2020 the Company acquired SLE, a leading global provider of neonatal ventilation products for £18 million.   Over 90% of SLE's revenues are generated from sales outside of the UK with a significant proportion of these in the Asia Pacific and the Middle East. When combined, the Group generates approximately 60 per cent. of its revenue from exports.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the U.K. and Ireland, the Company has a direct sales team selling Inspiration Healthcare Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com